CIK 0001712762 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465211056
- Phone
- 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-12 | DIAMOND STUART Director | Grant or award | +8,296 | 65,304 | ||
| 2024-06-12 | Anderson Robert A. Director | Grant or award | +8,296 | 130,152 | ||
| 2024-04-08 | Zannes Maria President & CEO | Option exercise | +64,848 | $1.16 | $75K | 229,506 |
| 2024-04-08 | Zannes Maria President & CEO | Shares withheld for taxes | −28,264 | $2.65 | $75K | 201,242 |
| 2024-04-08 | Zannes Maria President & CEO | Option exercise · Stock Option (right to buy) | −64,848 | 0 | ||
| 2024-04-04 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Option exercise | +64,848 | $1.16 | $75K | 75,155 |
| 2024-04-04 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Shares withheld for taxes | −29,031 | $2.58 | $75K | 46,124 |
| 2024-04-04 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Option exercise · Stock Option (right to buy) | −64,848 | 0 | ||
| 2024-04-03 | GIRGENTI STEVEN Director | Option exercise | +64,848 | $1.16 | $75K | 1,056,606 |
| 2024-04-03 | GIRGENTI STEVEN Director | Shares withheld for taxes | −33,438 | $2.24 | $75K | 1,023,168 |
| 2024-04-03 | GIRGENTI STEVEN Director | Option exercise · Stock Option (right to buy) | −64,848 | 0 | ||
| 2024-02-26 | Anderson Robert A. Director | Option exercise | +64,848 | $1.16 | $75K | 121,856 |
| 2024-02-26 | Anderson Robert A. Director | Option exercise · Stock Option (right to buy) | −64,848 | 0 | ||
| 2024-02-16 | GIRGENTI STEVEN Executive Chairman | Grant or award | +39,474 | $1.52 | $60K | 991,758 |
| 2024-01-31 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Grant or award | +6,688 | 10,307 | ||
| 2024-01-31 | Zannes Maria President, CEO | Grant or award | +23,885 | 164,658 | ||
| 2024-01-31 | Reveles Xavier Trinidad Chief Operating Officer | Grant or award | +16,720 | 20,339 | ||
| 2024-01-31 | Rebel Vivienne I Chief Sci. & Med. Officer, EVP | Grant or award | +31,847 | 46,228 | ||
| 2024-01-31 | GIRGENTI STEVEN Executive Chairman | Grant or award | +11,943 | 952,284 | ||
| 2024-01-31 | Dougherty Michael Philip Chief Financial Officer | Grant or award | +31,847 | 84,203 |
Page 2 of 10 · 183 trades